Synthesis and characterization of chemical engineered PLGA nanosphere: Triggering mechanism of Catechol-O-methyltransferase inhibition on in vivo neurodegeneration

Bioorg Chem. 2023 Oct:139:106673. doi: 10.1016/j.bioorg.2023.106673. Epub 2023 Jun 16.

Abstract

Chemically engineered PLGA nanospheres are one of the emerging technologies for treating neurodegenerative disorders by inhibiting Catechol-O-methyltransferase (COMT). PLGA-MATPM nanospheres were chemically synthesized using PLGA and MATPM (N-allyl-N-(3-(m-tolyloxy)propyl) methioninate). The tailored PLGA nanospheres induce dose-dependent COMT inhibition in competitive kinetic mode. The interactions between COMT and PLGA nanosphere are explained by spectroscopic and molecular dynamics analysis. PLGA-MATPM NPs suppressed the growth of neuroblastoma cells due to the neurodegenerative toxicity of MPTP induction, demonstrating its potency as a cure for neurological disorders. PLGA-MATPM NPs cross the blood-brain barrier more effectively than those in the blood. Furthermore, PLGA nanospheres showed the most neurodegenerative recovery against MPTP-induced C57BL/6 mice. Using magnetic resonance imaging (MRI), it was validated for quality images of cerebral blood flow (CBF).

Keywords: Catechol-O-methyltransferase; Enzyme kinetics; MR imaging; Neuroblastoma; PLGA nanosphere.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Catechol O-Methyltransferase Inhibitors / pharmacology
  • Catechol O-Methyltransferase* / metabolism
  • Methylation
  • Mice
  • Mice, Inbred C57BL
  • Nanospheres* / chemistry

Substances

  • Catechol O-Methyltransferase
  • Catechol O-Methyltransferase Inhibitors